Get the Weekly Intelligence Brief — top committee picks every Sunday.
NASDAQ · STOCK

Universal Health Services

UHS Healthcare Unknown Updated July 31, 2026
$168.59
52W $140.08 – $246.33
58/100
$10.20B
6.9
1.07
AI Committee Verdict
Buy
Conviction: Contested · 43% agreement · 7 analysts
+44.5%
-16.9%
2.64:1
Contested

Is UHS Bullish or Bearish?

Bullish. Innellis AI committee rates Universal Health Services (UHS) Buy with a composite score of 58/100 , based on 7 analysts with 43% agreement. Last updated July 31, 2026.

What Would Change This View

Upgrade to Strong Buy
Requires a committee score of 75.0 — +16.69 from today. Applies on the first day at or above the line; upgrades are never dampened.
Downgrade to Watch
Requires the score to fall below 55.0 — -3.31 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.

Executive Summary

The committee is genuinely divided. Growth Analyst sees a compelling case — eps growing 29.4% yoy. Risk Analyst remains cautious — bollinger bandwidth of 15.9% signals elevated volatility. This disagreement is itself the signal — the setup is not clean in either direction.

Bull & Bear Case

Bull Case
  • P/E of 6.4 is inexpensive for the broad market — Value
  • ROE of 20.8% shows genuine earnings power backing the valuation — Value
  • EPS growing 29.4% YoY — Growth
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
  • MACD histogram positive -- bullish momentum — Technical
  • Market regime is bullish (Bull market -- normal position sizing) — Macro
Bear Case
  • Bollinger bandwidth of 15.9% signals elevated volatility — Risk
Both cases are generated from quantitative data signals, not qualitative or forward-looking judgement. They summarise what the numbers say today.
Price History (6M)

AI Investment Committee

Committee Consensus As of July 31, 2026
Overall Committee Score
58/100
Agreement
43%
Analysts
7
Conviction
Contested
Sector Rank
Top 22%
of 93 Healthcare peers
Value Analyst bullish
70 / 100 · Moderate confidence
Classic value case: cheap on multiples with earnings power to back it up
+ P/E of 6.4 is inexpensive for the broad market
Growth Analyst bullish
78 / 100 · High confidence
Strong, accelerating growth with consistent execution
+ EPS growing 29.4% YoY
Technical Analyst neutral
58 / 100 · High confidence
Mixed or range-bound price action
+ MACD histogram positive -- bullish momentum
Risk Analyst bearish
35 / 100 · Low confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− Bollinger bandwidth of 15.9% signals elevated volatility
Macro Analyst neutral
58 / 100 · Moderate confidence
Macro backdrop is mixed or neutral -- not a strong tailwind or headwind either way
+ Market regime is bullish (Bull market -- normal position sizing)
News Analyst bullish
64 / 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.20 across 35 articles, 14d)
Portfolio Manager neutral
45 / 100 · High confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− Sector concentration is already high (HHI 2744.14)
Open Full Terminal →

Investment Thesis Evolution

Committee score moved marginally from 58.0 to 58.3.

Analyst-level changes:
  • Macro Analyst: stance bullish->neutral; score 65->58 (-8); +1 bullish signal(s).
  • Portfolio Manager: +2 bearish signal(s).
  • Risk Analyst: +1 bearish signal(s).
  • Technical Analyst: score 48->58 (+10).
  • Value Analyst: +1 bullish signal(s).

Comparing 2026-07-30 to 2026-07-31 (1 day apart).

Technical Analysis

RSI (14)
71.0
Overbought
MACD Histogram
1.883
Bullish Momentum
Trend Direction
Sideways
Weekly: Downtrend
Market Structure
Mixed
Support
$140.14
Resistance
$243.66
Bollinger %B
0.96
Inside Bands
Price vs Moving Averages
EMA 9
$161.22 Above
EMA 21
$156.73 Above
EMA 50
$156.99 Above
EMA 200
$176.65 Below

Fundamental Analysis

Valuation
100
Growth
63
Profitability
1
Financial Health
58
Cash Flow
36
Valuation
P/E Ratio 6.9×
P/B Ratio 1.37×
PEG Ratio 0.26
Dividend Yield 0.00%
52W High $246.33
52W Low $140.08
Quality & Growth
ROE 20.5%
ROA 9.3%
Gross Margin 51.4%
Operating Margin 11.4%
Revenue Growth YoY
Debt / Equity 0.70
AI Fundamental Assessment
P/E ratio of 6.9 (inexpensive relative to a 15-40x range); Price-to-book of 1.4x; PEG ratio of 0.3 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 0.2%; Return on assets of 0.1%; Net margin of 0.1%; Gross margin of 0.5%; Current ratio of 1.12 (tight short-term liquidity); Debt-to-equity of 0.70; Free cash flow margin of 0.5% (thin cash generation); Free cash flow per share is positive (13.54); Most recent quarter missed estimates by 0.6%; EPS growth accelerating (-4.4% -> +6.4% QoQ); Average YoY EPS growth of 11.8%; Analyst estimates flat over recent quarters
Get the Full UHS Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →

Explore UHS Further

📈 Rating History 💰 Earnings 📰 Recent Events 🔄 What Changed 📖 Thesis Evolution 🔍 Similar Stocks
Weekly Intelligence Brief
Get the committee's top-scored stocks every Sunday.
Free · No spam · Unsubscribe anytime